Access1 Access2 Access3 Cancer Medication & Drugs May 19, 2022 HSA Approves First-In-Class Sacituzumab Govitecan (Trodelvy) for Metastatic Triple Negative Breast Cancer (mTNBC)
Access1 Access2 Access3 Medication & Drugs Skin May 5, 2022 HSA Approves New JAK inhibitor Abrocitinib (Cibinqo) For The Treatment of Atopic Dermatitis
Access1 Access2 Access3 Medication & Drugs Mental Health March 31, 2022 Esketamine (Spravato) for Treatment Resistant Depression
Access1 Access2 Access3 Medication & Drugs Muscles & Joints March 17, 2022 Upadacitinib (Rinvoq): Once-Daily Oral Treatment for Rheumatoid Arthritis (RA)
Access1 Access2 Access3 Medication & Drugs Nervous System Uncategorized February 2, 2022 Eptinezumab (Vyepti) for preventive treatment of both episodic and chronic migraine
Infectious Disease Medication & Drugs January 25, 2022 Molnupiravir for COVID-19? 5 Things You Need To Know About This Oral Drug
